Zinc to Treat Tinnitus in the Elderly

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

116 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-01-31

Study Completion Date

2011-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There is widespread belief and some evidence to indicate that zinc can successfully treat tinnitus. Zinc deficiency is more likely to occur in the elderly . The primary objective of this study is to establish the effectiveness of zinc for the treatment of tinnitus in individuals 60 years of age and older. Subjects will be randomly assigned to either receive zinc daily or a placebo. After 4 months and a 1-month wash-out, the subjects will be crossed over to the other group.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Improvement of Tinnitus After Oral Zinc on Patients With Noise-induced Hearing Loss

NCT02951715

Hearing Loss, Noise-Induced Tinnitus, Noise Induced Zinc Deficiency

COMPLETED NA

The Efficacy of Incobotulinum Toxin A Injections for Treatment of Tinnitus: a Randomized Controlled Trial

NCT05650645

Tinnitus

COMPLETED PHASE2

A Trial of Magnesium Dependent Tinnitus

NCT01273883

Tinnitus

COMPLETED PHASE3

Nitrous Oxide Treatment for Tinnitus

NCT03365011

Tinnitus

COMPLETED PHASE4

Clinical Trial of Acamprosate for Tinnitus

NCT00596531

Tinnitus

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

There is widespread belief and some evidence to indicate that zinc can successfully treat tinnitus. Zinc deficiency is more likely to occur in the elderly . The primary objective of this study is to establish the effectiveness of zinc for the treatment of tinnitus in individuals 60 years of age and older. Subjects will be randomly assigned to either receive zinc daily or a placebo. After 4 months and a 1-month wash-out, the subjects will be crossed over to the other group. 116 patients were tested. Tinnitus loudness and the Tinnitus Handicap Questionnaire are the outcome measures.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tinnitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

placebo pill

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1 - zinc placebo

Zinc sulfate (50 mg elemental zinc) taken once daily for 4 months. Washout 1 month. Placebo oral capsule taken once a day for 4 months.

Group Type EXPERIMENTAL

Zinc

Intervention Type DRUG

Zinc taken once daily

Placebo oral capsule

Intervention Type DRUG

Placebo capsules taken once daily

2 - placebo zinc

Placebo oral capsule taken once a day for 4 months. Washout 1 month. Zinc sulfate (50 mg elemental zinc) taken once daily for 4 months.

Group Type EXPERIMENTAL

Zinc

Intervention Type DRUG

Zinc taken once daily

Placebo oral capsule

Intervention Type DRUG

Placebo capsules taken once daily

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Zinc

Zinc taken once daily

Intervention Type DRUG

Placebo oral capsule

Placebo capsules taken once daily

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

zinc sulfate Placebo

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 60 years of age or older
* Tinnitus for 6 months or more
* Normal copper levels
* Be generally healthy

Exclusion Criteria

* Have a treatable otological disorder
* Involved in litigation
* Have or are suspected of having a serious psychiatric problem
* Involved in other treatments for tinnitus
* Are taking drugs which might interact with zinc and result in tinnitus
* Have copper deficiency
* Have Zinc levels above normal
* Are cognitively impaired.

Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No